Pharmaceutical Care in Ambulatory Hemodialysis Patients
NCT ID: NCT02452788
Last Updated: 2015-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trial to Compare 1.0 Versus 2.0 mg Alteplase (tPA) Dosing in Restoring Hemodialysis Catheter Function
NCT02225782
Study of Self-monitoring of Weight & Blood Pressure (Via patientMpower Platform) in Hemodialysis
NCT03403491
Effects of a Mindfulness-based Intervention in Stress, Pain and Quality of Life in People Undergoing Hemodialysis
NCT04610593
Impact of Hospital Pharmacist Intervention on Medication Management in Dialysis Patients
NCT06692231
The Use of Furosemide in Patients on Dialysis
NCT01815892
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Pharmaceutical care with educational intervention provided by a pharmacist to ambulatory hemodialysis patients
Pharmaceutical care
Pharmacist-provided education on medication adherence in hemodialysis patients.
Usual Care
Usual Care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pharmaceutical care
Pharmacist-provided education on medication adherence in hemodialysis patients.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic renal patients undergoing regular hemodialysis
* Receiving their scheduled medications (at least one drug)
Exclusion Criteria
* Inability to obtain prescription drugs
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Moinhos de Vento
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisiane F Leal, MBA
Role: PRINCIPAL_INVESTIGATOR
Hospital Moinhos de Vento
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Moinhos de Vento
Porto Alegre, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AMhem-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.